nyse биржа 01.04.11
EXC – Bullish MACD Crossovers (NYSE)
BBD – Moved Above Upper Bollinger Band (NASDAQ)
POT – CCI Buy signals (NYSE)
MOS – Parabolic SAR Buy signals (NYSE)
FCX – New Uptrend (ADX) (NYSE)
MAS – Bearish MACD Crossovers (NYSE)
SEMG – Moved Below Lower Bollinger Band (NYSE)
AIG – CCI Sell signals (NYSE)
LOW – Parabolic SAR Sell signals (NYSE)
DAL – New Downtrend (Aroon) (NYSE)
- Alexander & Baldwin Inc. (ALEX 45.65, +0.12, +0.26%) shares climbed in late–trading Thursday after a regulatory filing showed Pershing Square Capital Management, run by activist hedge-fund manager Bill Ackman, has purchased a 8.6% stake in the ocean–transportation and logistics–services company for $148.1 million. The filing indicated the move was made with Marcato Capital Management, which has a 1.3% stake in Alexander & Baldwin. The filing also indicated that Pershing believes Alexander & Baldwin’s shares are undervalued and are an attractive investment.
- Christopher & Banks (CBK 6.48, +0.09, +1.41%) late Thursday issued a weaker–than–expected fiscal fourth–quarter outlook. The women’s apparel retailer expects to take a loss of 47 cents to 51 cents a share on sales of $99.6 million. Analysts polled by Thomson Reuters had foreseen a loss of just 31 cents a share on revenue of $100 million.
- Health products retailer GNC Holdings is set to begin public trading on Friday. Analysts say the initial public offering remains significantly oversubscribed.
- Krispy Kreme (KKD 7.04, +0.21, +3.07%) could be primed to move lower Friday following its disappointing fourth–quarter results. The doughnut retailer late Thursday reported a loss of $1.5 million, or 2 cents a share, after posting earnings of $500,000, or 1 cent a share, in the same period a year earlier. Sales rose nearly 6% to $91.7 million. Analysts polled by FactSet Research were expecting a profit of 4 cents a share on sales of $93 million.
- Monster Worldwide (MWW 15.90, -0.16, -1.00%) , Dice Holdings Inc. (DHX 15.11, -0.16, -1.05%) , Manpower Inc. (MAN 62.88, +1.36, +2.21%) and other recruitment–related stocks could react Friday to the latest monthly U.S. employment report. A survey of economists by Dow Jones Newswires is projecting an increase of 195,000 jobs in March.
- Omeros’s (OMER 8.00, +0.20, +2.56%) stock plunged in after–hours trading Thursday on negative news related to its OMS103HP drug, which is designed to help patients recover from ankle surgery. The biopharmaceutical firm said the drug candidate failed to meet the pre–specified endpoints of its Phase 3 program studies.
- Xyratex’s (XRTX 11.16, -0.16, -1.41%) shares fell in late–trading Thursday after the data–storage provider reported disappointing first–quarter revenue. The company said adjusted net income was $7.5 million, or 24 cents a share, compared with earnings of $29.4 million, or 96 cents, in the year–ago period. Revenue rose 13% to $360.5 million. Analysts polled by Thomson Reuters were anticipating revenue of $374.3 million